Important Events & Dates:

Deadline for Submission of Phase 2 Deliverables – 15th of January 2024
 View information
Deadline for Submission of Phase 1 Deliverables – 15th of August 2022
 View information
Prior Information Notice (PIN) published on 28.12.2020
 Download PDF Lot Information
Open Market Consultation (OMC)
 View Partnering Platform
Request for Tenders – published on the 19th of October 2021
 View Request for Tenders
Tendering Webinar 3rd November 2021 15:00-17:00 CET
 View recording
Deadline for Tenders´ Receipt – 19th of December 2021

A Pre-Procurement Project for improving cancer patients’ benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmocogenetics testing and e-medication in proper presentation to medical doctors for supporting therapy decision making at bedside.


This 65 month H2020 project started in January 2020. 
The maximum Grant Agreement amount is €10.998.128,16  

 Cofunded by the European Union under Grant Agreement No. 874719